Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06932237 · ClinicalTrials.gov registry record
Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans
A clinical trial of Long COVID and Neuro-PASC, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT06932237 is a study of Long COVID and Neuro-PASC that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 200 participants, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06932237, a study of Long COVID and Neuro-PASC, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
Mental health symptoms, including cognitive impairment ("brain fog"), following COVID-19 are of great concern to Veterans. The investigators' research seeks to advance understanding of the long-term effects of COVID-19 on neuropsychiatric and neurological functions, identifying clinically relevant biomarkers and directions for developing and testing therapeutic interventions. To accomplish these objectives the investigators are conducting a longitudinal study at two VA medical centers to: 1) assess and monitor cognitive function and psychiatric symptoms in Veterans post-COVID; 2) evaluate biomarkers of inflammation and signaling pathways associated with viral infection and neuropsychiatric function; and 3) integrate neuropsychiatric and neurological findings with biological data to identify biomarkers and clinical endpoints associated with disease progression or severity, as well as those for promoting brain repair and attenuating those symptoms.
Conditions Studied
Study Locations (2)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Tennessee
- James H. Quillen VA Medical Center, Mountain Home, TN - Mountain Home
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-02-20 |
| Est. Completion | 2028-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06932237
The ClinicalTrials.gov registry entry for NCT06932237 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (91% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Long COVID appearing as the primary indexed condition, and to 0 interventions.
NCT06932237 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oregon, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06932237 about?
NCT06932237 is a clinical study titled "Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans". Mental health symptoms, including cognitive impairment ("brain fog"), following COVID-19 are of great concern to Veterans. The investigators' research seeks to advance understanding of the long-term effects of COVID-19 on neuropsychiatric and neurological functions, identifying clinically relevant b...
What is the current status of trial NCT06932237?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-02-20. Estimated completion is 2028-03-31.
What conditions does trial NCT06932237 study?
This clinical trial studies the following conditions: Long COVID, Neuro-PASC.
Who is sponsoring clinical trial NCT06932237?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06932237 being conducted?
This trial has 2 study locations across Oregon, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RECRUITING · Phase 3
-
Sauna for Long Covid
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.